نتایج جستجو برای: pediatric aml and prognosis

تعداد نتایج: 16873517  

2015
Marco Togni Riccardo Masetti Martina Pigazzi Annalisa Astolfi Daniele Zama Valentina Indio Salvatore Serravalle Elena Manara Valeria Bisio Carmelo Rizzari Giuseppe Basso Andrea Pession Franco Locatelli

The genomic landscape of children with acute myeloid leukemia (AML) who do not carry any cytogenetic abnormality (CN-AML) is particularly heterogeneous and challenging, being characterized by different clinical outcomes. To provide new genetic insights into this AML subset, we analyzed through RNA-seq 13 pediatric CN-AML cases, corroborating our findings in an independent cohort of 168 AML pati...

Evaluation of ATG7 and LC3 Autophagy Genes Expression in Newly Diagnosed AML patients Background and aim: Autophagy, known as cell death type II, is a housekeeping pathway that currently has been worked on in matters of tumorigenesis and leukemogenesis. Therefore, in this study expression levels of ATG7 and LC3 as two key genes are targeted in AML patients. Material and method: This...

2015
Yan-Fang Tao Li-Xiao Xu Jun Lu Shao-Yan Hu Fang Fang Lan Cao Pei-Fang Xiao Xiao-Juan Du Li-Chao Sun Zhi-Heng Li Na-Na Wang Guang-Hao Su Yan-Hong Li Gang Li He Zhao Yi-Ping Li Yun-Yun Xu Hui-Ting Zhou Yi Wu Mei-Fang Jin Lin Liu Xue-Ming Zhu Jian Ni Jian Wang Feng Xing Wen-Li Zhao Jian Pan

BACKGROUND Pediatric acute myeloid leukemia (AML) comprises up to 20% of all childhood leukemia. Recent research shows that aberrant DNA methylation patterning may play a role in leukemogenesis. The epigenetic silencing of the EBF3 locus is very frequent in glioblastoma. However, the expression profiles and molecular function of EBF3 in pediatric AML is still unclear. METHODS Twelve human acu...

2017
Askar Obulkasim Jenny E. Katsman-Kuipers Lonneke Verboon Mathijs Sanders Ivo Touw Mojca Jongen-Lavrencic Rob Pieters Jan-Henning Klusmann C. Michel Zwaan Marry M. van den Heuvel-Eibrink Maarten Fornerod

Pediatric acute myeloid leukemia (AML) is a heterogeneous disease with respect to biology as well as outcome. In this study, we investigated whether known biological subgroups of pediatric AML are reflected by a common microRNA (miRNA) expression pattern. We assayed 665 miRNAs on 165 pediatric AML samples. First, unsupervised clustering was performed to identify patient clusters with common miR...

Journal: :iranian journal of pediatric hematology and oncology 0
r masoumi-dehshiri nutrition and food security research centre, shahid sadoughi university of medical sciences, yazd, iran as hashemi hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h neamatzadeh hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h zare-zardini hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

acute myeloid leukemia (aml-m7) is a type of pediatric aml accounting for 3–10% of primary childhood aml and children may present with a broad variety of symptoms including low-grade fever, diarrhea, easy bruising, failure to gain weight and life-threatening conditions. we report a rare case of aml .a 26-month-old boy who presented with weakness and fatigue. he was diagnosed as a case of amlm-7...

2014
Ghaleb Elyamany Mohammad Awad Kamal Fadalla Mohamed Albalawi Mohammad Al Shahrani Abdulaziz Al Abdulaaly

The Fms-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase that plays a key role in cell survival, proliferation, and differentiation of hematopoietic stem cells. Mutations of FLT3 were first described in 1997 and account for the most frequent molecular mutations in acute myeloid leukemia (AML). AML patients with FLT3 internal tandem duplication (ITD) mutations have poor cure rates the...

2011
Xuelian Xu Chengzhi Xie Holly Edwards Hui Zhou Steven A. Buck Yubin Ge

BACKGROUND Pediatric acute myeloid leukemia (AML) remains a challenging disease to treat even with intensified cytarabine-based chemotherapy. Histone deacetylases (HDACs) have been reported to be promising therapeutic targets for treating AML. However, HDAC family members that are involved in chemotherapy sensitivities remain unknown. In this study, we sought to identify members of the HDAC fam...

2015
Jasmijn D. E. de Rooij C. Michel Zwaan Marry van den Heuvel-Eibrink Celalettin Ustun

Pediatric acute myeloid leukemia (AML) represents 15%-20% of all pediatric acute leukemias. Survival rates have increased over the past few decades to ~70%, due to improved supportive care, optimized risk stratification and intensified chemotherapy. In most children, AML presents as a de novo entity, but in a minority, it is a secondary malignancy. The diagnostic classification of pediatric AML...

عبدالملکی, سارا, معماریان, علی,

Background & Objectives: Defect in Immune responses, such as immunosuppression is one of the major causes of AML pathogenesis and progression which could be targeted for immunotherapy of these patients. CD200 and IDO are immunoregulatory factors which are overexpressed in some solid tumors and hematological malignancies. Distinct researches have shown that CD200 and IDO expressions are associat...

Background: Somatic mutations in the hotspot region of the DNA-methyltransferase 3A (DNMT3A) gene were recurrently identified in acute myeloid leukemia (AML). It is believed that DNMT3A mutations confer an adverse prognosis for AML patients. These lines of evidence support the need for a rapid and cost-efficient method for the detection of these mutations. The present study aimed to establish h...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید